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Comparison of 3-month visual outcomes
of a spherical and a toric trifocal
intraocular lens
Q7 Francisco Poyales, MD, Nuria Garzon, PhD
Purpose: To evaluate visual outcomes and satisfaction after im-
plantation of 2 trifocal intraocular lenses (IOLs): a spherical IOL
and a toric IOL.
Setting: IOA Madrid Innova Ocular, Madrid, Spain.
Design: Prospective, controlled clinical trial.
Methods: Patients (>50 years) were implanted bilaterally with
either a trifocal spherical hydrophilic IOL (FineVision POD F) if
corneal astigmatism was 1.0 diopter (D) or less or withQ1 a trifocal
toric hydrophilic IOL (FineVision POD FT) if astigmatism was
more than 1.0 D. Outcomes analyzed 3 months after surgery
included monocular and binocular visual acuities at distance,
near and intermediate, both uncorrected and corrected. Defocus
curves, contrast sensitivity and patient satisfaction were also
assessed.
Results: There was no statistically significant difference between
groups in monocular uncorrected distance (UDVA) (P Z .38),
monocular corrected distance (CDVA) (P Z .22), or distance-
corrected intermediate (DCIVA) (P Z .95) visual acuities;
however, the distance-corrected near visual acuity (DCNVA) was
slightly better in the spherical IOL group (P Z .008). The UDVA
was 20/25 or better in 89% of eyes in the spherical IOL group
and 93% in the toric IOL group. The DCIVA was 20/32 or better
in 92% of eyes in the spherical IOL group and 93% in the toric
IOL group at 80 cm (Radner Vissum chart), and 20/32 or better
in 100% of eyes in both groups at 63 cm (Colenbrander chart).
The DCNVA (Radner chart) was 20/32 or better in 89% of eyes in
the spherical IOL group and 90% of eyes in the toric IOL group.
There was no difference between the groups in contrast
sensitivity, defocus curves, cylinder, or satisfaction results.
Conclusion: Patients had significant improvement in visual acuity
and gained functional uncorrected visual acuity across all distances
in both groups. Satisfaction was high with both IOLs.
J Cataract Refract Surg 2018;-:-–- Q 2018 ASCRS and ESCRS
The advent of multifocal intraocular lenses (IOLs)has enabled correction of not only spherocylindricalrefractive errors, but also for presbyopia. Multifocal
IOLs aim to improve uncorrected vision at near and inter-
mediate distances1 without compromising uncorrected
distance visual acuity (UDVA).2,3 Multifocal IOLs have
also been shown to improve visual rehabilitation, in partic-
ular, in providing patient independence for different work-
ing distances as well as reducing spectacle dependence.4,5
However, halos, glare, and reduced contrast sensitivity
continue to be reported with presbyopia-correcting
IOLs.6,7
Multifocal IOLs can be broadly categorized based on
their design: either concentric focal zones (alternating for
near, intermediate, or far) or segmented, two zones (bifocal)
with one zone for distance and the other for near. One
known issue with these designs is a reduced visual acuity
at intermediate distances.8–10 To overcome this, trifocal
IOLs were developed to provide improved vision at inter-
mediate distances.
This is achieved with a diffractive surface with three foci,
including the addition of intermediate vision atC1.75 di-
opters (D).11–13 In addition, the FineVision (Physiol S.A.)
design results in the lens becoming distance-dominant
when the pupil reaches 4.5 mm. This design evolution is ex-
pected to result in higher patient satisfaction compared
with patients who have monofocal or bifocal IOLs im-
planted.14 The potential for an increase in halos because
of the addition of a third focal point was a concern; howev-
er, photic phenomena and contrast sensitivity reduction are
minimized as a result of the relatively low energy that is
dedicated to intermediate vision when compared with dis-
tance and near vision foci.15
The FineVision POD F (Physiol, S.A.) is a diffractive
trifocal spherical hydrophilic IOL that provides an interme-
diate focus at 1.75 D and a near focus at 3.5 D at the IOL
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plane. The FineVision POD FT (Physiol, S.A.) is trifocal
toric hydrophilic IOL with astigmatic correction with cylin-
drical correction up to 6 D.
The goal of this clinical study was to evaluate visual per-
formance at the 3 working distancesdfar, intermediate,
and neardas well as patient satisfaction outcomes of the
spherical IOL (POD F) and the toric IOL (POD FT) in pa-
tients with preexisting corneal astigmatism. Patients with
1.00 D or less of corneal astigmatism were implanted bilat-
erally with the spherical IOL, whereas those with more than




This was a prospective comparative cohort study of patients who
had cataract surgery between September 2014 and December 2016
at IOA Madrid Innova Ocular, Madrid, Spain. All patients pro-
vided written informed consent before enrollment. This study
was approved by the local ethical committee and was performed
in accordance with the Declaration of Helsinki and its subsequent
revisions.
Patients were grouped 1:1 to have binocular implantation of
either the trifocal spherical IOL (POD F) or the trifocal toric
IOL (POD FT), depending on the amount of preexisting corneal
astigmatism.
Patients
Eligible patients were at least 50 years of age, with cataractous eyes
and no comorbidities. Specific inclusion criteria were regular
corneal astigmatism of 1.00 D or less for the spherical IOL and
more than 1.0 D of regular corneal astigmatism for the toric
IOL. Other inclusion criteria included the desire for spectacle in-
dependence after surgery with realistic expectations and availabil-
ity and willingness to comply with examination procedures.
Key exclusion criteria were irregular astigmatism, ocular co-
morbidities, history of ocular trauma or previous ocular surgery
including refractive procedures, acute or chronic disease or illness
that would increase risk or confound study results, capsule or zon-
ular abnormalities that might affect postoperative centration or tilt
of the lens (eg, pseudoexfoliation syndrome, chronic uveitis, Mar-
fan syndrome), and patients with pupil abnormalities.
Preoperative Assessment
Before surgery, patients had an extensive ophthalmologic exami-
nation. This included uncorrected and corrected monocular visual
acuities testing at far, intermediate, and near distances. Visual acu-
ity was measured under photopic lighting conditions with a chart
luminance of approximately 85 candelas (cd)/m2. Distance was
measured at 4.0 m (Early Treatment Diabetic Retinopathy Study
[ETDRS], Precision Vision), intermediate at 80 cm (Radner Vis-
sum, NeuMed AG, AT, Precision Vision) and 63 cm (Co-
lenbrander, Precision Vision), and near at 40 cm (Radner
Vissum, NeuMed AG, AT, Precision Vision). Topography was
performed using a high-resolution rotating Scheimpflug device
(Pentacam HR, Oculus Optikger€ate GmbH). Refraction, slitlamp
evaluation, spectral-domain optical coherence tomography
(OCT) (Cirrus, Carl Zeiss Meditec AG), and fundoscopy were
also performed.
The corneal keratometry, axial length, and anterior chamber
depth were measured with swept-source OCT (IOLMaster 700,
Carl Zeiss Meditec AG). Once the corneal power was estimated,
the required IOL power was computed using either the Barrett
II Universal formulaA or the Barrett Toric formulaB with an opti-
mized constant (119.02). The target refraction was calculated with
the simulated keratometry valueQ2 , considering the surgically
induced astigmatism (SIA). In all cases, the target was
emmetropia.
Intraocular Lenses
The trifocal spherical IOL (POD F) combines 2 diffractive struc-
tures adjusted to offer C3.5 D addition for near vision and
C1.75 D addition for intermediate vision. This corresponds to a
nominal intermediate addition of approximately C1.2 D and
near addition of about C2.4 D at the corneal plane, depending
on the geometry of the eye. The optic is biconvex aspheric
(0.11 mm spherical aberration) diffractive. Q3The lens is 26% hy-
drophilic acrylic with an ultraviolet and blue light blocker and
an optic body diameter of 6.00 mm, overall diameter of
11.40 mm, refractive index of 1.46, angulation of 5 degrees, and
power fromC6.0 D toC35.0 D.
The trifocal toric IOL (POD FT) has the same design and ma-
terial as the trifocal spherical IOL, with the possibility of correcting
astigmatism up to 6.0 D at the IOL plane because of the toric pos-
terior lens surface geometry.
Surgical Technique
All surgical procedures were performed by the same experienced
surgeon (F.P.) under topical anesthesia and aided by a
computer-assisted cataract surgery system (Callisto Eye, Zeiss
Cataract Suite Markerless, Carl Zeiss Meditec AG). For the cata-
ract procedure, a 2.2 mm angled 45 degree, bevel-up surgical knife
(Xstar Safety Slit Knife, Beaver-Visitec International) was used to
create a 2.2 mm self-sealing clear corneal incision at 180 degrees
(temporal) in right eyes and at 90 degrees (superior) in left eyes
and approximately 1.00mm anterior to the limbus. Next, a contin-
uous curvilinear capsulorhexis measuring approximately 5.5 mm
in diameter was created. Two ophthalmic viscosurgical devices
(OVDs)dcohesive sodium hyaluronate 1.0% (Healon (Johnson
& Johnson Vision Care, Inc.) and dispersive sodium hyaluronate
1.2% (Amvisc, Bausch & Lomb, Inc.)dwere used during the sur-
gery. The chosen IOL was then implanted in the capsular bag with
a single-use injection system (Accujet, Medicel AG) and posi-
tioned using the computer-assisted cataract surgery system. Ac-
cording to the clinical center’s protocol on premium IOLs, a
capsular tension ring (CTR) was inserted in all eyes undergoing
cataract surgery. In all cases, after IOL insertion, all traces of
OVD were removed.
After insertion of the trifocal toric IOL, the lens was rotated un-
til the IOL markings agreed with the alignment marking.
Postoperative Assessment
The patients had follow-up visits at 1, 7, 30, and 90 days postop-
eratively. All examinations were performed by a single optometrist
(N.G.). Uncorrected monocular and binocular distance visual acu-
ities were measured at all visits.
Uncorrected and corrected distance visual acuities as well as un-
corrected and distance-corrected intermediate and near visual
acuities were measured at the 3-month visit. Intermediate visual
acuity was tested at 80 cm (Radner) and 63 cm (Colenbrander).
Near visual acuity was tested at 40 cm (Radner). Binocular defocus
curve testing was performed using a 100% contrast ETDRS chart
at 4.0 meters under photopic lighting conditions. The patients
were defocused with 4.0 D spherical correction from their best
distance correction in both eyes. Minus power was decreased in
0.5 D increments, and visual acuity was recorded for each defocus
step. The patients were subsequently defocused with C1.5 D
spherical correction from their distance correction, and plus
power was decreased in 0.5 D increments, with logarithm of the
minimum angle of resolution (logMAR) acuity recorded for
each defocus.
Contrast sensitivity was measured binocularly with correction
in place at spatial frequencies of 3, 6, 12, and 18 cycles per degree
(cpd) under photopic conditions at 85 cd/m2, and under mesopic
2 SPHERICAL VERSUS TORIC TRIFOCAL IOLS
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conditions at 6 cd/m2 using a contrast sensitivity tester (CST 1800
Digital, Vision Sciences Research Corp.).
Patient Satisfaction
Patient satisfaction and quality of life were determined by means
of an ad hoc questionnaire completed by patients at the
3-month visit. Questions included satisfaction about adaption be-
tween photopic and mesopic conditions, ability to find the correct
distance, night driving, vision during the day, halos, and adaption
between far and near vision and vice versa, as well as general satis-
faction for far vision, near vision, and intermediate vision, and
overall satisfaction. The last question was to ask patients whether
they would undergo surgery with implantation of the IOL again.
Each subscale score was converted to a score between 0 and 5,
with higher scores indicating better results.
Statistical Analyses
Statistical analyses were performed using an integrated statistics
software package (Stata 13.1 (Statacorp LLC). For comparison of
baseline demographics and clinical characteristics between
groups, categorical data were analyzed using the chi-square test.
For all quantitative variables, summary tables containing mean,
standard deviation, and range values were developed.
A repeated measure analysis of variance (ANOVA) was
computed to compare the 2 types of multifocal IOLs for visual
and refractive data with more than 2 timepoints with post hoc
Tukey-Kramer test if the ANOVA results showed statistical signif-
icance between groups. In the case of a simple timepoint, a Student
t test or Welch test was performed. A two-way ANOVA was per-
formed to analyze the difference between IOLs in defocus curves
and contrast sensitivity with post hoc Tukey-Kramer test. Results
from the questionnaire were analyzed using a Student t test or the
Welch test with a Cronbach aR 0.86 to compare the differences
between groups. A P value less than 0.05 was considered statisti-
cally significant.
Standards graphs for reporting cataract surgery outcomes were
used as per published recommendations.16 Error bars reflect the
standard deviation. A vector analysis of the change in astigmatism




This clinical trial enrolled 126 cataractous eyes (42 female
and 21 male) with a mean age of 62.5 years G 10.4 (SD).
The spherical IOL group consisted of 33 bilateral patients
(66.7% women) with a mean age of 63.0 G 7.9 years and
the toric IOL group consisted of 30 bilateral patients
(66.7% women) with a mean age of 62.0G 12.8 years.
The mean spherical power of the implanted in the spher-
ical IOL group was 21.55G 3.56 D (range 11.0 to 29.0 D)
and 19.81G 5.79 D (range 9.5 to 32.5 D) in the toric IOL
group; the mean cylindrical power in the toric IOL group
was 2.43G 1.24 D (range 1.0 to 6.0 D). Of the 30 patients
in the toric IOL group, 29 completed the 90-day follow-up.
Efficacy
Table 1 shows the visual acuity values at all distances in
both IOL groups at 3 months postoperatively.
Distance Visual Acuity There was no statistically signif-
icant difference between the 2 IOL groups in the mean
monocular UDVA at 3 months postoperatively
(PZ .38). Q4The binocular UDVA was good and slightly bet-
ter than monocular UDVA in both groups. The binocular
UDVA was statistically significantly better in the spherical
IOL group than in the toric IOL group (PZ .034); however,
the difference was only between 1 and 2 letters. Both groups
had UDVA better than 20/20 at 3 months.
There was no statistically significant difference between
the 2 IOL groups in the mean monocular corrected distance
visual acuity (CDVA) at 3 months postoperatively
(PZ .22). The binocular CDVA also improved compared
with monocular CDVA. It was statistically and significantly
better in the spherical IOL group than in the toric IOL
group (PZ .038); however, the difference was only between
1 and 2 letters.
Table 1. Overview of 3-month postoperative visual acuity outcomes in logMAR, and comparison between the 2 IOL groups.
Visual Acuity
Mean ± SD
P ValueSpherical IOL Group Toric IOL Group
UDVA (ETDRS chart)
Monocular 0.03G 0.08 0.05G 0.08 .380
Binocular 0.04G 0.06 0.01G 0.05 .034
CDVA (ETDRS chart)
Monocular 0.00G 0.03 0.02G 0.03 .220
Binocular 0.06G 0.04 0.03G 0.05 .038
DCIVA @ 80 cm (Radner Vissum chart)
Monocular 0.12G 0.09 0.12G 0.09 .947
Binocular 0.09G 0.11 0.08G 0.08 .656
DCIVA @ 63 cm (Colenbrander chart)
Monocular 0.04G 0.06 0.08G 0.14 .030
Binocular 0.01G 0.06 0.01G 0.05 .162
DCNVA @ 40 cm (Radner Vissum chart)
Monocular 0.13G 0.10 0.17G 0.09 .009
Binocular 0.07G 0.08 0.11G 0.07 .036
CDVA Z corrected distance visual acuity; DCIVA Z distance-corrected intermediate visual acuity; DCNVA Z distance-corrected near visual acuity;
ETDRS Z Early Treatment Diabetic Retinopathy Study; IOL Z intraocular lens; logMAR Z logarithm of the minimum angle of resolution;
UDVAZ uncorrected distance visual acuity
3SPHERICAL VERSUS TORIC TRIFOCAL IOLS
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Figure 1, A, shows the distribution of monocular UDVA
and CDVA in the spherical IOL group and Figure 1, B, in
the toric IOL group. At 3 months postoperatively, 59
(89%) of 66 eyes in the spherical IOL group and 56 (93%)
of 60 eyes in the toric IOL group had 20/25 or better
UDVA, with 65 eyes (98%) and 58 eyes (97%) achieving
20/32 or better UDVA, respectively.
Figure 2, A, shows the distribution of binocular UDVA
and CDVA in the spherical IOL group and Figure 2, B, in
the toric IOL group. At 3 months postoperatively, 60
(91%) of 66 eyes in the spherical IOL group and 52 (86%)
of 60 eyes in the toric IOL group had 20/20 or better
UDVA, with 64 eyes (97%) and 60 eyes (100%) achieving
20/25 or better UDVA, respectively.
Intermediate Visual Acuity There was no statistically
significant difference between the 2 IOL groups in mean
monocular postoperative distance-corrected intermediate
visual acuity (DCIVA) (P Z .95) (Table 1). The DCIVA
was assessed at 80 cm and 63 cm. There was no statistically
significant difference between the 2 IOL groups in mean
binocular DCIVA at 80 cm (P Z .66). Using the Co-
lenbrander chart, the DCIVA was slightly better at 63 cm
than at 80 cm. The mean monocular DCIVA at 63 cm
was statistically and significantly better in the spherical
IOL group than in the toric IOL group (PZ .030); however,
the difference was only 2 letters. The binocular DCIVA at
63 cm was not statistically different between the 2 groups
(PZ .162).
Figure 3, A, shows the distribution of monocular DCI-
VA at 80 cm in both groups and Figure 3, B, shows the
distribution of binocular DCIVA in both groups. At
3 months postoperatively, 31 (92%) of the 33 patients in
the spherical IOL group and 28 (93%) of the 30 patients
in the toric IOL group could see 20/32 or better uncorrec-
ted monocularly at 80 cm. Binocularly, 30 (91%) of the 33
patients in the spherical IOL group and 30 (100%) of the
30 patients in the toric IOL group could read 20/32 at
80 cm. Figure 3, C, shows the distribution of monocular
DCIVA at 63 cm in both IOL groups, and Figure 3, D,
shows the distribution of binocular DCIVA at 63 cm in
both groups.
Near Visual Acuity The mean monocular postoperative
distance-corrected near visual acuity (DCNVA) at 40 cm
was statistically and significantly better in the spherical
IOL group than in the toric IOL group (P Z .009)
(Table 1). Again, the difference was only 2 letters. The
binocular DCNVA at 40 cmwas also statistically and signif-
icantly better in the spherical IOL group (PZ .036).
Figure 1. A: Monocular UDVA and CDVA
in the spherical IOL group. B: Monocular
UDVA and CDVA in the toric IOL group
(CDVA Z corrected distance visual acu-
ity; IOL Z intraocular lens; mon Z
monocular; UDVA Z uncorrected dis-
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Figure 2. A: Binocular UDVA and CDVA in
the spherical IOL group. B: Binocular
UDVA and CDVA in the toric IOL group
(binZ binocular; CDVAZ corrected dis-
tance visual acuity; IOL Z intraocular
lens; UDVA Z uncorrected distance vi-
sual acuity; VAZ visual acuity).
Figure 3. A: Monocular DCIVA at 80 cm. B: Binocular DCIVA at 80 cm. C: Monocular DCIVA at 63 cm. D: Binocular DCIVA at 63 cm
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Figure 4, A, shows the distribution of monocular
DCNVA at 40 cm in both groups, and Figure 4, B, shows
the distribution of binocular DCNVA in both groups. At
3 months postoperatively, 29 (89%) of 33 patients in the
spherical IOL group and 27 (90%) of 30 patients in the toric
IOL group could see 20/32 uncorrected monocularly.
Binocularly, 61 (97%) of all 63 patients could read 20/32.
Refraction
At 3 months postoperatively, the mean sphere was
0.01G 0.22 D (range 0.75 toC0.50 D) and 0.00G 0.2
7D (range 1.00 to C0.75 D), the mean cylinder was
0.14 G 0.31D (range 1.25 to 0.0 D) and 0.19 G 0.36
D (range 1.5 to 0.0 D), and the manifest refraction
spherical equivalent (MRSE) was 0.08 G 0.21 D
Figure 4. A: Monocular DCNVA at 40 cm.
B: Binocular DCNVA at 40 cm (DCNVAZ
distance-corrected near visual acuity;
IOL Z intraocular lens; VA Z visual acu-
ity).
Figure 5. Spherical equivalent refraction
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(range 0.75 to 0.5 D) and 0.09G 0.27 D (range 1.0 to
0.5 D) in the spherical IOL group and the toric IOL group,
respectively.
Figure 5 shows the distribution of the MRSE at 3 months
postoperatively; 62 (94%) of the 66 eyes in the spherical IOL
group and 56 (93%) of the 60 eyes in the toric IOL group
were within G0.5 D of the target refraction and 100% of
eyes were within G1.0 D of the target refraction in both
groups.
Figure 6 shows the distribution of the refractive cylinder
at 3 months postoperatively in both IOL groups; 59 (89%)
of the 66 eyes in the spherical IOL group and 52 (86%) of
the 60 eyes in the toric IOL group had 0.50 D or less of
residual astigmatism.
Figure 7 shows the planned astigmatic correction (target-
induced astigmatism [TIA] vector analysis [7, A]); the SIA
is shown in 7, B, whereas 7, C, shows the vectorial difference
between the preoperative target and the SIA changes. The
mean difference vector was 0.15 D at 97 degrees, which
indicates an effective correction of cylinder.
Defocus Curve
Figure 8 shows the defocus curves in both groups. As would
be expected, both IOLs performed similarly with a visual
acuity peak at 0.00 D and an acuity of 20/20 or better in
both groups. From C1.00 D to 3.0 D, visual acuity was
0.13 logMAR or better (20/27 or better) in both IOL groups,
showing that a good visual acuity was maintained at all dis-
tances from far to near. In the near range, there was a peak
at 2.5 D (corresponding to an approximate distance of
40 cm).
Contrast Sensitivity
Figures 9, A and B, show the photopic and mesopic contrast
sensitivity at 1.5, 3, 6, 12 and 18 cpd in both IOL groups.
The observed mean contrast sensitivity with both IOLs
was within the normal band of the age group (56 to 75 years)
for all spatial frequencies except for 12 cpd. Although it was
not statistically significant (P Z .05), a trend toward
reduced contrast sensitivity with the spherical IOL versus
the toric IOL was observed.
Patient Questionnaire
Table 2 shows results from the questionnaire in both IOL
groups. There were no statistically significant differences
between the groups, and both groups reported high levels
of satisfaction. In the spherical IOL group, 30 (96.8%) of
31 patients indicated that they would have the same surgery
again, and 25 (89.3%) of 28 patients in the toric IOL group
said the same (PZ .337; Fisher exact test).
Complications
There were no complications in either IOL group.
DISCUSSION
In this study, refractive and visual outcomes as well as qual-
ity of life outcomes were reported after bilateral implanta-
tion of 2 trifocal IOLs: a spherical IOL and a toric IOL. In
general, both IOLs performed well with good quality of
vision at distance, intermediate, and near; good refractive
accuracy; and high levels of satisfaction from the patients.
The visual outcomes showed excellent unaided visual
acuity for both spherical and toric models. Previously pub-
lished studies have assessed visual outcomes after implanta-
tion of multifocal IOLs, including a recent metaanalysis by
Rosen,18 which examined published results of multifocal
IOLs and reported a mean postoperative UDVA of 0.05
logMAR and a mean binocular UDVA of 0.04 logMAR.
These findings are similar to our study, which showed a
mean of 0.03G 0.08 logMAR in the spherical IOL group,
and 0.05G 0.08 logMAR in the toric IOL group. However,
in our study, binocular UDVA was improved by one line
compared with monocular UDVA, and it was better than
20/20 in both groups:0.04G 0.06 (20/18) in the spherical
IOL group and 0.01 G 0.05 (20/19) in the toric IOL
group.
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Distance-corrected near and intermediate visual acuity
were also excellent with both IOLs. A previous study on
the FineVision toric IOL had already demonstrated
improved intermediate vision with no loss of far and near
vision.15 Furthermore, comparison studies have demons-
trated that a trifocal toric IOL also improved intermediate
vision without negatively affecting near or distance visual
acuity relative to a bifocal toric IOL, with good rotation
Figure 7. Standard graphs for reporting outcomes
for astigmatism correction, based on the Alpins
Method. Single-angle polar plots for the target-
induced astigmatism vector (A), the surgically
induced astigmatism vector (B), and the Difference
vector (C). The vector means are plotted as red dia-
monds, with the blue dots representing single point
dwith most eyes at 0 D, which demonstrates the
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stability and low postoperative refractive astigmatism.19
The mean monocular DCIVA was 0.09 logMAR in the
spherical IOL group and 0.08 logMAR in the toric IOL
group at 80 cm, which was better than the value of 0.20
logMAR achieved with the M-flex T multifocal toric IOL
(Rayner Intraocular Lenses Ltd.), and also slightly better
than previously reported values for the POD FineVision
(0.15 logMAR).20
Figure 8. The defocus curve for both IOLs
(IOL Z intraocular lens; logMAR Z logarithm
of the minimum angle of resolution).
Figure 9. Photopic (A) and mesopic (B)
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Binocular DCNVA at 40 cm was good and similar be-
tween both IOLs: 0.07 G 0.08 logMAR (20/23) in the
spherical IOL group and 0.11 G 0.07 logMAR (20/26) in
the toric IOL group. This is also comparable to other multi-
focal IOLs. For example, the M-flex T IOL withC3.0 D add
provided a mean DCVNA of 0.08 LogMAR.15
In comparing visual acuity performance between the 2
IOLs: POD F and POD FT, some statistically significant dif-
ferences were found. However, the differences were always
less than 0.05 logMAR or half a line of visual acuity, and
therefore not considered clinically significant. The defocus
curve results were in alignment with the visual acuity find-
ings, confirming that visual acuity above 20/25 was main-
tained over a defocus range of 4 D from C1.00 D to
3.00 DQ5 , indicating good quality of vision from far to near
distances of up to 33 cm. The defocus curves confirmed
that there was no gap in vision at the intermediate distances.
In terms of refractive accuracy, both IOLs performed
similarly, which was to be expected as the diffractive designs
are identical. Over 93% of eyes were withinG0.50 D of the
target refraction for both IOLs and all eyes were within
G1.00 D of the target refraction. The toric IOL was effective
in correcting astigmatism, with 93% of eyes after surgery
with 0.75 D or less of residual astigmatism. This was compa-
rable to 95% of eyes with 0.75 D of residual astigmatism in
the spherical IOL group. This demonstrated that the correc-
tion of astigmatismwas accurate within the toric IOL group.
In this study, two tools were employed to aid in the post-
operative outcome. In all eyes, a CTR was inserted before
IOL insertion. Based on our experience, the use of a CTR
reduces the likelihood of capsular folds and creases appear-
ing in the posterior capsule. In other studies, a reduction of
ocular wavefront errors because of better positioning of the
IOLs are reported or a combination of using trifocal and
bifocal lenses provided good efficacy, predictability, and
safety and increased the intraocular optical performance.20
Other reasons for use of a CTR are an increased stabiliza-
tion of the capsular bag and reduced problems related to
IOL decentration and tilt.21,22 The second tool was the
Callisto eye, which was used to guide the implantation of
all IOLs, to ensure fixation over the patients’ optical axis,
as well as to place the toric IOL on the proper axis.
Loss of contrast sensitivity because of the distribution of
total available light between several focal points in a refrac-
tive toric multifocal IOL is a known fact.23 In this study,
contrast sensitivity showed small differences under photopic
conditions between the spherical IOL and the toric IOL, but
no differences under mesopic conditions. The contrast
sensitivity levels measured with POD F and POD FT were
comparable to levels obtained from another published study
that used an illuminated viewer system (CSV-1000, Vector-
vision, Inc.) (1.56 G 0.15 at 3 cpd, 1.80 G 0.16 at 6 cpd,
1.50G 0.15 cpd, and 0.93G 0.25 at 18 cpd).24 Previously,
Marques and Ferreira25 found no significant differences in
contrast sensitivity between eyes implanted with the AT
LISA tri IOL (Carl Zeiss Meditec AG) and a FineVision
trifocal IOL, with the contrast sensitivity within the normal
range, a finding that was confirmed by others.6 This trend
toward reduced contrast sensitivity results with toric trifocal
IOLs in comparison to nontoric trifocal IOLs can be seen in
clinical outcomes using an IOL with a very similar optic
design (AT LISA tri and AT LISA tri toric). As with the
investigated Physiol trifocal IOLs, the published literature
by the authors on the Carl Zeiss Meditec AT LISA IOLs
demonstrated a similar difference in contrast sensitivity be-
tween toric and nontoric IOL models.26,27
It is well recognized that assessment of subjective percep-
tion of vision is an important part of multifocal IOL assess-
ment. In this study, patients reported high levels of
satisfaction after surgery. It is interesting to note that pa-
tients were equally satisfied with the quality of their vision
at distance, intermediate, and near distances. This confirms
the objective visual acuity measurements and defocus
curves demonstrating equal quality of vision at all distances.
Quality of vision during the day, and the ability to find the
correct distance were scored the highest by the study pa-
tients. Night driving problems, in particular halos, were re-
ported as low by the patients. The appearance of halos is
Table 2. Results from the questionnaire evaluation to show the mean scores in the 2 IOL groups for various domains of
satisfaction.
Evaluatory Parameter
Spherical IOL Group Toric IOL Group
P ValuePatients (n)
Mean
Score ± SD Patients (n)
Mean
Score ± SD
General satisfaction w/far vision 32 4.2G 0.6 28 4.4G 0.7 .348*
General satisfaction w/near vision 32 4.1G 0.8 28 3.9G 1.2 .418†
General satisfaction w/intermediate vision 32 4.2G 0.8 28 4.5G 0.6 .226*
Adaption between photopic and mesopic conditions 32 4.0G 1.0 28 4.5G 0.6 .087†
Ability to find the correct distance 32 4.9G 0.1 28 4.9G 0.2 .496†
Night driving 21 3.5G 0.7 14 3.7G 0.7 .461*
Vision during day 32 4.5G 0.8 28 4.2G 1.1 .212*
Halos 31 2.3G 1.1 28 2.5G 1.1 .624*
Adaption between far and near visual acuity and vice versa 32 4.5G 0.7 28 4.4G 0.6 .715*
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one of the most common light phenomena reported by pa-
tients after multifocal IOL implantations and it was ranked
the same for both the FineVision spherical and the toric
models.16,28–31 Furthermore, it has been shown previously
that the incidence of symptoms tends to reduce with
time, likely because of a neuroadaptation process. This
will be the subject of a future study with a longer follow-up.
In conclusion, our study of the spherical POD F IOL and
the toric POD FT IOL 3months after surgery demonstrated
good vision at a range of distances, with excellent accuracy
and a high patient satisfaction rate. The toric POD FT offers
the option of correcting astigmatism without compro-
misingQ6 accuracy and quality of vision.
WHAT WAS KNOWN
 Multifocal IOLs have been shown to improve uncorrected
near visual acuity compared with monofocal IOLs, without
compromising UDVA. However, halos, glare, and reduced
contrast sensitivity remained compromises associated with
multifocal IOLs.
 Several toric multifocal IOLs are available to correct for both
astigmatism and presbyopia, including the FineVision POD
FT IOL.
WHAT THIS PAPER ADDS
 The spherical POD F IOL and the toric POD FT IOL
demonstrated excellent vision at a range of distances, with
excellent accuracy and a high rate of patient satisfaction.
 The toric POD FT offers the option of correcting astigmatism
without compromising accuracy and quality of vision.
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